Health Condition 1: L80- Vitiligo
Conditions
Interventions
Intervention1: nil: nil
Sponsors
Dr Lavin Bhatia
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with stable lesions. 2.Patients between 18 and 60 years of age. 3.Patients who give informed consent for the study and photography. 4.Patients who can follow up in the opd
Exclusion criteria
Exclusion criteria: 1.Patients who are unwilling to participate in the study. 2.Patients who had used any topical treatment 2 weeks and systemic treatment 4 weeks before starting on KUVA SOL. 3.Patients with history of photosensitive disorders, skin cancer, hepatic or renal disease and lesions over genitals. 4.Pregnant or lactating women. 5.Unstable vitiligo. 6.Patients with spontaneous repigmentation of depigmented macules.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.VASI ( Vitiligo Area Scoring Index) 2.VIDA ( Vitiligo Disease Activity) 3.VAS ( Visual Analogue Scale) 4.Scoring by Dermosopy Image Processing Methodology. 5. Side Effects. Timepoint: Every 4 weeks of initiating therapy for total of 16 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Liver function tests. 2. Renal function tests. 3. complete blood count. Timepoint: 0, 8 weeks, 16weeks. | — |
Countries
India
Contacts
Public ContactDr Sathish Pai B
Kasturba Medical College and Kasturba Hospital, Manipal Academy of Higher Education
Outcome results
None listed